Introduction: It is still unknown whether the combination of IFNα with octreotide LAR has benefit compared with IFNα alone
Aim(s): Тo compare efficacy and toxicyty of IFNα and IFNα plus Octreotide LAR in first line of therapy of patients with NETs
Materials and methods: 50 pts with morphologically verified well differentiated advanced NETs(G1-2), 16 (32%) men and 34 (68%) women, mean age 55 (19-80). IFNα(n=19): lung–11(58%); GEP–8(42%). Grade: G1–8(42%); G2–11(58%). IFNα+Octreotide LAR(n=31): lung–6(19%); GEP–25(81%).Grade:G1–11(35%); G2–20(65%)
Conference: 12th Annual ENETS Conference 2015 (2015)
Category: Medical treatment - SMS analogues, interferon
Presenting Author: Galina Emelianova
To read results and conclusion, please login ...
Further abstracts you may be interested in